PAVmed Inc. - Common Stock, $0.001 par value per share (PAVM)
CUSIP: 70387R403
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 6,578,769
- Total 13F shares
- 952,389
- Share change
- +198,697
- Total reported value
- $2,032,208
- Price per share
- $2.14
- Number of holders
- 22
- Value change
- +$362,293
- Number of buys
- 7
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 70387R403:
Top shareholders of PAVM - PAVmed Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
302,606
|
$1,246,737 | — | 31 Dec 2023 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
3%
|
200,000
|
$824,000 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
74,922
|
$308,678 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
55,078
|
$226,984 | — | 31 Dec 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.34%
|
22,561
|
$92,951 | — | 31 Dec 2023 | |
| Valeo Financial Advisors, LLC |
13F
|
Company |
0.32%
|
21,129
|
$87,051 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.32%
|
20,981
|
$86,442 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
12,957
|
$53,383 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.17%
|
11,418
|
$47,042 | — | 31 Dec 2023 | |
| XML Financial, LLC |
13F
|
Company |
0.16%
|
10,334
|
$42,576 | — | 31 Dec 2023 | |
| James L. Cox |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| Joan B. Harvey |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
6,617
mixed-class rows
|
$24,856 | — | 31 Dec 2023 | |
| CWM, LLC |
13F
|
Company |
0.07%
|
4,672
|
$19,000 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.06%
|
3,772
|
$15,541 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
2,584
|
$10,646 | — | 31 Dec 2023 | |
| Glassman Wealth Services |
13F
|
Company |
0.04%
|
2,319
|
$9,554 | — | 31 Dec 2023 | |
| Allworth Financial LP |
13F
|
Company |
0.02%
|
1,024
|
$4,219 | — | 31 Dec 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
991
|
$4,000 | — | 31 Dec 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
182
|
$748 | — | 31 Dec 2023 | |
| M&R CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
67
|
$276 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
30
|
$123 | — | 31 Dec 2023 | |
| Rockbridge Investment Management, LCC |
13F
|
Company |
0%
|
27
|
$112 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
115
mixed-class rows
|
$72 | — | 31 Dec 2023 | |
| THOMPSON INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0%
|
4
|
$16 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Dec 2023 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Dec 2023 | |
| Brian J. DeGuzman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
50,000
|
— | — | 18 Feb 2022 |
Institutional Holders of PAVmed Inc. - Common Stock, $0.001 par value per share (PAVM) as of Q1 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.